Annals of Nuclear Medicine

Papers
(The H4-Index of Annals of Nuclear Medicine is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Assessing dedicated breast PET performance in breast cancer screening alongside digital mammography, digital breast tomosynthesis, and ultrasound: a reader's insight57
Correction: Novel indices representing heterogeneous distributions of myocardial perfusion imaging38
Conversion from dose length product to effective dose for the CT component of whole-body PET/CT32
Clinical perspective on targeted alpha therapy using 225Ac29
A first-in-man study of [18F] FEDAC: a novel PET tracer for the 18-kDa translocator protein26
Utility of serum blood ketone levels and other risk factors for inadequate myocardial glucose suppression ketogenic FDG-PET/CT: a prospective and retrospective cohort study23
Highly specific amyloid and tau PET ligands for ATN classification in suspected Alzheimer’s disease patients22
[18F]FDG PET/CT is useful in discriminating invasive adenocarcinomas among pure ground-glass nodules: comparison with CT findings—a bicenter retrospective study22
Vision-language model performance on the Japanese Nuclear Medicine Board Examination: high accuracy in text but challenges with image interpretation21
Semiquantitative analysis using whole-body dynamic F-18 fluoro-2-deoxy-glucose–positron emission tomography to differentiate between benign and malignant lesions21
18F-FET PET/CT can aid in diagnosing patients with indeterminate MRI findings for brain tumors: a prospective study21
A first-in-man PET study of 2-amino-[3-11C] isobutyric acid for the amino acid transport System A: biodistribution and dosimetry in healthy volunteers20
Research trends and hotspots of radioiodine-refractory thyroid cancer treatment in the twenty-first century: a bibliometric analysis19
FAPI radiopharmaceuticals in nuclear oncology and theranostics of solid tumours: are we nearer to surrounding the hallmarks of cancer?19
J-ACCESS investigation and nuclear cardiology in Japan: implications for heart failure18
Increase of prostate-specific antigen doubling time predicts survival in metastatic castration-resistant prostate cancer patients undergoing radium therapy18
Correction: Practice recommendation for measuring washout rates in 123I-BMIPP fatty acid images17
Correction: Clinical assessment and striatal dopaminergic activity in healthy controls and patients with Parkinson’s disease: a Bayesian approach17
0.16907000541687